Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
09/2010
09/22/2010CN101311197B Degradable pH-sensitive hydrogel copolymer, method for preparing same and use
09/22/2010CN101234094B Dipyridamole orally disintegrating tablet
09/22/2010CN101230135B Hydrogel materials based on ethylenediaminetetraacetic dianhydride and its uses
09/22/2010CN101224273B Preparing method of Jiaozhi soft capsule
09/22/2010CN101181626B Transfer factor capsule and preparation method thereof
09/22/2010CN101180042B Conjugate of biomacromolecule with bioreductive and preparative method thereof
09/22/2010CN101129335B Use of nano structured lipid carrier drug feeding system
09/22/2010CN101081234B Method for preparation of claybank propolis soft capsules
09/22/2010CN101032479B Ranitidine bismuth citrate medicine and its preparing process
09/21/2010US7799897 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
09/21/2010US7799794 Treatment for cardiovascular disease
09/21/2010US7799771 solid dosage form for contraceptives and hormone replacement therapy; very low moisture content to prevent ester hydrolysis; enhanced bioavailability of 17-beta-estradiol acetate; FDA Orange book listed patent for estradiol acetate
09/21/2010US7799762 Functionally substituted amino acids, having fatty acid chains bound through amidification of the amine functional groups of dipeptide like compounds, one end bears a functional side chain and other side neutral or charged acid
09/21/2010US7799549 Methods for increasing protein polyethylene glycol (PEG) conjugation
09/21/2010US7799540 Using fungal propagation and fermentation to generate carotenoids for use as food and pharmaceutical supplements
09/21/2010US7799345 Preparation of injectable suspensions having improved injectability
09/21/2010US7799333 Aqueous solution containing fatty alcohol, ethoxylated fatty alcohol and alkyl ether or carbonate; cosmetics
09/21/2010US7799327 Employing nonimmunogenic blood products from patients with autoimmune disease
09/21/2010US7799125 Yellow iron oxide pigments
09/21/2010CA2471416C Low water uptake silicas
09/21/2010CA2466770C Liquid pharmaceutical formulations of acetaminophen and an alkali metal 1-lactate salt
09/21/2010CA2451915C Crystalline composition containing escitalopram
09/21/2010CA2449521C Pharmaceutical formulation, its use, and method for its manufacture
09/21/2010CA2445068C Azo compounds for type i phototherapy
09/21/2010CA2441629C Antibiotic pharmaceutical composition with lysergol as bio-enhancer and method of treatment
09/21/2010CA2433280C Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
09/21/2010CA2416650C Enhancement of the action of central and peripheral nervous system agents
09/21/2010CA2393603C Microchip devices for delivery of molecules and methods of fabrication thereof
09/21/2010CA2345659C Biodegradable low molecular weight triblock polyester polyethylene glycol copolymers having reverse thermal gelation properties
09/21/2010CA2343074C Akt nucleic acids, polypeptides, and uses thereof
09/21/2010CA2325577C Polymer based rapidly dissolving tablets and production processes thereof
09/21/2010CA2307142C N-terminally chemically modified protein compositions and methods
09/21/2010CA2299950C Oral adhesive sheet and oral adhesive preparation
09/21/2010CA2251655C In vivo gene transfer methods for wound healing
09/16/2010WO2010105079A1 Complex of polymeric quaternary ammonium and anionic polymers as a new antimicrobial agent for ophthalmic compositions
09/16/2010WO2010104819A2 Hollow gold nanospheres (haunss) and haunss-loaded microspheres useful in drug delivery
09/16/2010WO2010104790A2 Fatty-acid based particles
09/16/2010WO2010104563A2 Highly compactable and durable direct compression excipients and excipient systems
09/16/2010WO2010104464A1 Oral delivery product
09/16/2010WO2010104170A1 Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide
09/16/2010WO2010104128A1 Ph-responsive liposome
09/16/2010WO2010104023A1 Infusion solution for administration to peripheral vein comprising carbohydrate solution having vitamin b1 contained therein stably
09/16/2010WO2010103959A1 Ameliorating agent for chronic obstructive pulmonary disease
09/16/2010WO2010103845A1 External preparation containing analgesic/anti-inflammatory agent
09/16/2010WO2010103844A1 External preparation containing analgesic/anti-inflammatory agent
09/16/2010WO2010103843A1 External preparation containing analgesic/anti-inflammatory agent
09/16/2010WO2010103374A2 Oily suspension containing probiotic bacteria for paediatric uses
09/16/2010WO2010103367A1 Pulsatile release composition of therapeutic agent
09/16/2010WO2010103118A1 Chemotherapeutic composition for the treatment of cancer
09/16/2010WO2010103022A2 Oil-in-water adjuvanted influenza vaccine
09/16/2010WO2010103017A2 Hapten-carrier conjugates with bacterial toxins having a signal peptide as carrier and their use in immunogenic compositions
09/16/2010WO2010102991A2 Riluzole liquid emulsions
09/16/2010WO2010102923A2 Riluzole aqueous suspensions
09/16/2010WO2010102862A1 Pharmaceutical formulation comprising ketoprofen and a polyoxyalkylene ester of a hydroxy fatty acid
09/16/2010WO2010102788A1 Prodrugs
09/16/2010WO2010102337A1 Injectable biomaterials
09/16/2010WO2010086881A3 Pharmaceutical compositions comprising phosphate-binding polymer
09/16/2010WO2010085665A3 Targeted delivery system
09/16/2010WO2010079047A3 Octreotide depot formulation with constantly high exposure levels
09/16/2010WO2010074711A3 Ceramic honeycomb structure skin coating
09/16/2010WO2010065329A3 Nanoparticles for cancer treatment
09/16/2010WO2010059963A3 Preparation and methodology of silk fibroin nanoparticles
09/16/2010WO2009147144A3 Composition comprising an antibiotic and a corticosteroid
09/16/2010WO2009106999A3 Hollow nanoparticles and uses thereof
09/16/2010WO2009083225A3 Antibody-containing formulation for the use for treating cardiovascular diseases associated with atherosclerosis
09/16/2010US20100234462 Topical composition
09/16/2010US20100234430 Methods and pharmaceutical formulations for protecting pharmaceutical compounds from acidic environments
09/16/2010US20100234329 Ingestible film composition
09/16/2010US20100234305 Polymeric delivery formulations of leuprolide with improved efficacy
09/16/2010US20100234299 Stable formulation of modified glp-1
09/16/2010US20100233264 TEMPERATURE AND pH-SENSITIVE BLOCK COPOLYMER HAVING EXCELLENT SAFTY IN VIVO AND HYDROGEL AND DRUG DELIVERY SYSTEM USING THEREOF
09/16/2010US20100233243 Laminated Microcapsule Sheet and Process For Production Thereof
09/16/2010US20100233237 Method and device for electrochemical formation of therapeutic species in vivo
09/16/2010US20100233232 Fatty-acid based particles
09/16/2010US20100233217 Organic compounds
09/16/2010US20100233216 Use of microvesicles (mvs) for preparing a medicament having adjuvant activity on endothelial cell transplantation, particularly in the treatment of diabetes by pancreatic islet transplantation, and related method
09/16/2010US20100233190 Targeted polymeric prodrugs containing multifunctional linkers
09/16/2010US20100233087 Cyp1b1 nucleic acids and methods of use
09/16/2010CA2787849A1 Injectable biomaterials
09/16/2010CA2755274A1 Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide
09/16/2010CA2755116A1 Ameliorating agent for chronic obstructive pulmonary disease
09/16/2010CA2755106A1 Complex of polymeric quaternary ammonium and anionic polymers as a new antimicrobial agent for ophthalmic compositions
09/16/2010CA2755084A1 Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
09/16/2010CA2754846A1 Prostate-specific antigen cleavable prodrugs
09/16/2010CA2754612A1 Oily suspension containing probiotic bacteria for paediatric use
09/16/2010CA2754592A1 Hapten-carrier conjugates with bacterial toxins having a signal peptide as carrier and their use in immunogenic compositions
09/16/2010CA2753685A1 Highly compactable and durable direct compression excipients and excipient systems
09/16/2010CA2752713A1 Pharmaceutical formulation comprising ketoprofen and a polyoxyalkylene ester of a hydroxy fatty acid
09/16/2010CA2748856A1 Riluzole aqueous suspensions
09/15/2010EP2228390A1 Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor
09/15/2010EP2228074A1 A tumor targeting protein conjugate and a method for preparing the same
09/15/2010EP2228068A1 Therapeutic agent for cerebral ischemic injury
09/15/2010EP2228066A1 Pharmaceutical compositions of sulphonylurea-based active pharmaceutical ingredient with excellent dissolution properties
09/15/2010EP2228063A1 Loxoprofen-containing aqueous plaster
09/15/2010EP2228060A1 Oral dosage forms comprising fenofibrate
09/15/2010EP2228058A1 Anionic oil-in-water emulsion containing prostaglandins and uses thereof
09/15/2010EP2228057A1 Cationic oil-in-water emulsions containing prostaglandins and uses thereof
09/15/2010EP2228055A1 Riluzole liquid emulsions
09/15/2010EP2228054A1 Riluzole aqueous suspensions
09/15/2010EP2227243A2 A pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate
1 ... 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 ... 1712